Voltar
Artigo Revisado por pares
BIBTEX RIS

Current awareness: Pharmacoepidemiology and drug safety

2010; Wiley; Volume: 19; Issue: 4 Linguagem: Inglês

10.1002/pds.1849

ISSN

1099-1557

Tópico(s)

Pharmacological Effects and Toxicity Studies

Resumo

Pharmacoepidemiology and Drug SafetyVolume 19, Issue 4 p. i-xiii Current Awareness Current awareness: Pharmacoepidemiology and drug safety First published: 26 March 2010 https://doi.org/10.1002/pds.1849AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Abstract In order to keep subscribers up-to-date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 23 sections: 1 Reviews; 2 General; 3 Anti-infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non-steroidal Anti-inflammatory Agents; 7 CNS Agents; 8 Anti-neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator-Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti-inflammatory Agents - Steroidal; 19 Teratogens/fetal exposure; 20 Antidiabetic Agents; 21 Contrast Agents; 22 Bone Conservation Agents; 23 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted. References 1. Reviews Google Scholar Special issue on contrast-induced nephropathy and nephrogenic systemic fibrosis. Radiol Clin North Am (2009); 47: Google Scholar Abel S, Back DJ, Vourvahis M. Maraviroc: Pharmacokinetics and drug interactions. Antivir Ther (2009); 14: 607. 10.3851/IMP1297 PubMedWeb of Science®Google Scholar Agbabiaka TB, Pittler MH, Wider B, Ernst E. Serenoa repens (saw palmetto): A systematic review of adverse events. Drug Saf (2009); 32: 637. 10.2165/00002018-200932080-00003 PubMedWeb of Science®Google Scholar Ali T, Roberts DN, Tierney WM. Long-term safety concerns with proton pump inhibitors. Am J Med (2009); 122: 896. 10.1016/j.amjmed.2009.04.014 CASPubMedWeb of Science®Google Scholar Boobis A, Watelet JB, Whomsley R, Benedetti MS, Demoly P, Tipton K. Drug interactions. Drug Metab Rev (2009); 41: 486. 10.1080/10837450902891550 CASPubMedWeb of Science®Google Scholar Bremmer MS, Bremmer SE, Baig-Lewis S, Simpson EL. Are biologics safe in the treatment of atopic dermatitis? A review with a focus on immediate hypersensitivity reactions. J Am Acad Dermatol (2009); 61: 666. 10.1016/j.jaad.2009.02.041 CASPubMedWeb of Science®Google Scholar Burtness B, Anadkat M, Basti S, Hughes M, Lacouture ME, McClure JS, Myskowski PL, Paul J, Perlis CS, Saltz L, Spencer S. NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer. J Natl Compr Canc Netw (2009); 7: S5. 10.6004/jnccn.2009.0074 PubMedWeb of Science®Google Scholar Byrne RA, Sarafoff N, Kastrati A, Schomig A. Drug-eluting stents in percutaneous coronary intervention: A benefit-risk assessment. Drug Saf (2009); 32: 749. 10.2165/11316500-000000000-00000 CASPubMedWeb of Science®Google Scholar Choti MA. Chemotherapy-associated hepatotoxicity: Do we need to be concerned?. Ann Surg Oncol (2009); 16: 2391. 10.1245/s10434-009-0512-7 PubMedWeb of Science®Google Scholar Culwell KR, Curtis KM. Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: A systematic review. Contraception (2009); 80: 337. 10.1016/j.contraception.2009.04.008 CASPubMedWeb of Science®Google Scholar Curtis KM, Ravi A, Gaffield ML. Progestogen-only contraceptive use in obese women. Contraception (2009); 80: 346. 10.1016/j.contraception.2009.04.006 CASPubMedWeb of Science®Google Scholar Fietta P, Fietta P, Delsante G. Central nervous system effects of natural and synthetic glucocorticoids. Psychiatry Clin Neurosci (2009); 63: 613. 10.1111/j.1440-1819.2009.02005.x CASPubMedWeb of Science®Google Scholar Fortinguerra F, Clavenna A, Bonati M. Psychotropic drug use during breastfeeding: A review of the evidence. Pediatrics (2009); 124: e547. 10.1542/peds.2009-0326 PubMedWeb of Science®Google Scholar Fournier MR, Targownik LE, Leslie WD. Proton pump inhibitors, osteoporosis and osteoporosis-related fractures. Maturitas (2009); 64: 9. 10.1016/j.maturitas.2009.07.006 CASPubMedWeb of Science®Google Scholar Gadhia K, Walmsley AD. Facial aesthetics: Is botulinum toxin treatment effective and safe? A systematic review of randomised controlled trials. Br Dent J (2009); 207: E9. 10.1038/sj.bdj.2009.813 CASPubMedWeb of Science®Google Scholar Gaffield ME, Kapp N, Curtis KM. Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease. Contraception (2009); 80: 363. 10.1016/j.contraception.2009.03.022 CASPubMedWeb of Science®Google Scholar Gaffield ME, Culwell KR, Ravi A. Oral contraceptives and family history of breast cancer. Contraception (2009); 80: 372. 10.1016/j.contraception.2009.04.010 CASPubMedWeb of Science®Google Scholar Godfrey J. Safety of therapeutic methylphenidate in adults: A systematic review of the evidence. J Psychopharmacol (2009); 23: 194. 10.1177/0269881108089809 CASPubMedWeb of Science®Google Scholar Higuchi K, Umegaki E, Watanabe T, Yoda Y, Morita E, Murano M, Tokioka S, Arakawa T. Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol (2009); 44: 879. 10.1007/s00535-009-0102-2 PubMedWeb of Science®Google Scholar Hoag JB, Azizi A, Doherty TJ, Lu J, Willis RE, Lund ME. Association of cetuximab with adverse pulmonary events in cancer patients: A comprehensive review. J Exp Clin Cancer Res (2009); 28: 113. 10.1186/1756-9966-28-113 CASPubMedWeb of Science®Google Scholar Hoet P, Legiest B, Geys J, Nemery B. Do nanomedicines require novel safety assessments to ensure their safety for long-term human use?. Drug Saf (2009); 32: 625. 10.2165/00002018-200932080-00002 CASPubMedWeb of Science®Google Scholar Izzedine H, Harris M, Perazella MA. The nephrotoxic effects of HAART. Nat Rev Nephrol (2009); 5: 563. 10.1038/nrneph.2009.142 CASPubMedWeb of Science®Google Scholar Kapp N, Tilley IB, Curtis KM. The effects of hormonal contraceptive use among women with viral hepatitis or cirrhosis of the liver: A systematic review. Contraception (2009); 80: 381. 10.1016/j.contraception.2009.04.007 CASPubMedWeb of Science®Google Scholar Kapp N, Curtis KM. Hormonal contraceptive use among women with liver tumors: A systematic review. Contraception (2009); 80: 387. 10.1016/j.contraception.2009.01.021 CASPubMedWeb of Science®Google Scholar Kefalakes H, Stylianides TJ, Amanakis G, Kolios G. Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: Myth or reality?. Eur J Clin Pharmacol (2009); 65: 963. 10.1007/s00228-009-0719-3 PubMedWeb of Science®Google Scholar Khazeni N, Bravata DM, Holty JEC, Uyeki TM, Stave CD, Gould MK. Systematic review: Safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza. Ann Intern Med (2009); 151: 464. 10.7326/0003-4819-151-7-200910060-00143 PubMedWeb of Science®Google Scholar Kuypers DRJ. Immunotherapy in elderly transplant recipients: A guide to clinically significant drug interactions. Drugs Aging (2009); 26: 715. 10.2165/11316480-000000000-00000 CASPubMedWeb of Science®Google Scholar Longo B, Forinash AB, Murphy JA. Levetiracetam use in pregnancy. Ann Pharmacother (2009); 43: 1692. 10.1345/aph.1M231 PubMedWeb of Science®Google Scholar Lopez JAM, Loza E, Carmona L. Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding). Clin Exp Rheumatol (2009); 27: 678. CASPubMedWeb of Science®Google Scholar Lucas S. Medication use in the treatment of migraine during pregnancy and lactation. Curr Pain Headache Reps (2009); 13: 392. 10.1007/s11916-009-0064-3 PubMedWeb of Science®Google Scholar Marzano AV, Vezzoli P, Crosti C. Drug-induced lupus: An update on its dermatologic aspects. Lupus (2009); 18: 935. 10.1177/0961203309106176 CASPubMedWeb of Science®Google Scholar McFarlane SI. Insulin therapy and type 2 diabetes: Management of weight gain. J Clin Hypertens (2009); 11: 601. 10.1111/j.1751-7176.2009.00063.x PubMedWeb of Science®Google Scholar Miller MT, Ventura L, Stromland K. Thalidomide and misoprostol: Ophthalmologic manifestations and associations both expected and unexpected. Birth Defects Res A Clin Mol Teratol (2009); 85: 667. 10.1002/bdra.20609 CASPubMedWeb of Science®Google Scholar Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GFM. Benefits and harms of phosphate binders in CKD: A systematic review of randomized controlled trials. Am J Kidney Dis (2009); 54: 619. 10.1053/j.ajkd.2009.06.004 CASPubMedWeb of Science®Google Scholar Oesch F. Importance of knowledge on drug metabolism for the safe use of drugs in humans. Drug Metab Rev (2009); 41: 298. 10.1080/10837450902890958 CASPubMedWeb of Science®Google Scholar Raj SR, Stein CM, Saavedra PJ, Roden DM. Cardiovascular effects of noncardiovascular drugs. Circulation (2009); 120: 1123. 10.1161/CIRCULATIONAHA.107.728576 PubMedWeb of Science®Google Scholar Salisbury AL, Ponder KL, Padbury JF, Lester BM. Fetal effects of psychoactive drugs. Clin Perinatol (2009); 36: 595. 10.1016/j.clp.2009.06.002 PubMedWeb of Science®Google Scholar Somech R, Weber EA, Lavi S. Evaluation of immediate allergic reactions to cephalosporins in non-penicillin-allergic patients. Int Arch Allergy Immunol (2009); 150: 205. 10.1159/000222672 CASPubMedWeb of Science®Google Scholar Southey ER, Soares-Weiser K, Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin (2009); 25: 2207. 10.1185/03007990903116255 CASPubMedWeb of Science®Google Scholar Sperber K, Hom C, Chao CP, Shapiro D, Ash J. Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatr Rheumatol (2009); 7: 9. 10.1186/1546-0096-7-9 PubMedWeb of Science®Google Scholar Svetitsky S, Leibovici L, Paul M. Comparative efficacy and safety of vancomycin versus teicoplanin: Systematic review and meta-analysis. Antimicrob Agents Chemother (2009); 53: 4069. 10.1128/AAC.00341-09 CASPubMedWeb of Science®Google Scholar Theou-Anton N, Faivre S, Dreyer C, Raymond E. Benefit-risk assessment of sunitinib in gastrointestinal stromal tumours and renal cancer. Drug Saf (2009); 32: 717. 10.2165/00002018-200932090-00003 CASPubMedWeb of Science®Google Scholar Vitiello B, Correll C, Van Zwieten-Boot B, Zuddas A, Parellada M, Arango C. Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns. Eur Neuropsychopharmacol (2009); 19: 629. 10.1016/j.euroneuro.2009.04.008 CASPubMedWeb of Science®Google Scholar Wang YG, Swick TJ, Carter LP, Thorpy MJ, Benowitz NL. Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): Abuse, misuse, dependence, and diversion. J Clin Sleep Med (2009); 5: 365. CASPubMedWeb of Science®Google Scholar Wiens A, Correr CJ, Pontarolo R, Venson R, Quinalha JV, Otuki MF. A systematic review and meta-analysis of the efficacy and safety of etanercept for treating rheumatoid arthritis. Scand J Immunol (2009); 70: 337. 10.1111/j.1365-3083.2009.02296.x CASPubMedWeb of Science®Google Scholar Zammit G. Comparative tolerability of newer agents for insomnia. Drug Saf (2009); 32: 735. 10.2165/11312920-000000000-00000 CASPubMedWeb of Science®Google Scholar Zhanel GG, Ketter N, Rubinstein E, Friedland I, Redman R. Overview of seizure-inducing potential of doripenem. Drug Saf (2009); 32: 709. 10.2165/00002018-200932090-00001 CASPubMedWeb of Science®Google Scholar 2. General Google Scholar Asano Y, Kagawa H, Kano Y, Shiohara T. Cytomegalovirus disease during severe drug eruptions: Report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome. Arch Dermatol (2009); 145: 1030. 10.1001/archdermatol.2009.195 PubMedWeb of Science®Google Scholar Atiqi R, Cleophas TJ, Van Bommel E, Zwinderman AH. Meta-analysis of recent studies on patients admitted to hospital due to adverse drug effects. Int J Clin Pharmacol Ther (2009); 47: 549. 10.5414/CPP47549 CASPubMedWeb of Science®Google Scholar Barbaud A. Drug patch tests in the investigation of cutaneous adverse drug reactions (French, English Abstract). Ann Dermatol Venereol (2009); 136: 635. 10.1016/j.annder.2009.06.021 CASPubMedWeb of Science®Google Scholar Bourgeois FT, Mandl KD, Valim C, Shannon MW. Pediatric adverse drug events in the outpatient setting: An 11-year national analysis. Pediatrics (2009); 124: e744. 10.1542/peds.2008-3505 PubMedWeb of Science®Google Scholar Jeschke E, Ostermann T, Luke C, Tabali M, Kroz M, Bockelbrink A, Witt CM, Willich SN, Matthes H. Remedies containing Asteraceae extracts: A prospective observational study of prescribing patterns and adverse drug reactions in German Primary Care. Drug Saf (2009); 32: 691. 10.2165/00002018-200932080-00007 PubMedWeb of Science®Google Scholar Jordan S, Emery S, Watkins A, Evans JD, Storey M, Morgan G. Associations of drugs routinely given in labour with breastfeeding at 48 hours: Analysis of the Cardiff Birth Survey. BJOG (2009); 116: 1622. 10.1111/j.1471-0528.2009.02256.x CASPubMedWeb of Science®Google Scholar Kamisako T. Present status of drug-induced liver injury (DILI) in Japan: Is a proposed diagnostic scale useful? (Editorial). Hepatol Res (2009); 39: 949. 10.1111/j.1872-034X.2009.00595.x CASPubMedWeb of Science®Google Scholar Marsh J, Hager C, Havey T, Sprague S, Bhandari M, Bryant D. Use of alternative medicines by patients with OA that adversely interact with commonly prescribed medications. Clin Orthop Related Res (2009); 467: 2705. 10.1007/s11999-009-0764-3 PubMedWeb of Science®Google Scholar Phipps DL, Noyce PR, Parker D, Ashcroft DM. Medication safety in community pharmacy: A qualitative study of the sociotechnical context. BMC Health Serv Res (2009); 9: 158. 10.1186/1472-6963-9-158 PubMedWeb of Science®Google Scholar Ray A. Beyond debacle and debate: Developing solutions in drug safety. Nat Rev Drug Discov (2009); 8: 775. 10.1038/nrd2988 CASPubMedWeb of Science®Google Scholar Tchen T, Reguiai Z, Vitry F, Arnoult E, Grange A, Florent G, Bernard P. Usefulness of skin testing in cutaneous drug eruptions in routine practice. Contact Dermatitis (2009); 61: 138. 10.1111/j.1600-0536.2009.01578.x CASPubMedWeb of Science®Google Scholar Van Roon EN, Van den Bemt PMLA, Jansen TLTA, Houtman NM, Van de Laar MAFJ, Brouwers JRBJ. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists. Clin Ther (2009); 31: 1737. 10.1016/j.clinthera.2009.08.009 CASPubMedWeb of Science®Google Scholar Wierenga PC, Lie-A-Huen L, De Rooij SE, Klazinga NS, Guchelaar HJ, Smorenburg SM. Application of the Bow-Tie model in medication safety risk analysis consecutive experience in two hospitals in the Netherlands. Drug Saf (2009); 32: 663. 10.2165/00002018-200932080-00005 PubMedWeb of Science®Google Scholar Wise L, Parkinson J, Raine J, Breckenridge A. New approaches to drug safety: A pharmacovigilance tool kit. Nat Rev Drug Discov (2009); 8: 779. CASPubMedWeb of Science®Google Scholar 3. Anti-infective Agents Google Scholar Belda A, Borras-Blasco J, Lopez-Montes L, Rosique-Robles D, Castera E, Abad J. Foot ischaemia and toe skin necrosis associated with interleukin-2 infusion in an HIV-infected patient. Int J STD AIDS (2009); 20: 577. 10.1258/ijsa.2008.008282 PubMedWeb of Science®Google Scholar Bellon A, Perez-Garcia G, Coverdale JH, Chacko RC. Seizures associated with levofloxacin: Case presentation and literature review. Eur J Clin Pharmacol (2009); 65: 959. 10.1007/s00228-009-0717-5 CASPubMedWeb of Science®Google Scholar Bines JE, Patel M, Parashar U. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception. J Infect Dis (2009); 200: S282. 10.1086/605051 PubMedWeb of Science®Google Scholar Blanche S, Bologna R, Cahn P, Rugina S, Flynn P, Fortuny C, Vis P, Sekar V, Van Baelen B, Dierynck I, Spinosa-Guzman S. Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents. AIDS (2009); 23: 2005. 10.1097/QAD.0b013e328330abaa CASPubMedWeb of Science®Google Scholar Boet S, Noblet C, Haas-Hubscher C, Picard D, Musette P, Dureuil B. Severe vancomycin-induced drug rash with eosinophilia and systemic symptoms syndrome imitating septic shock (Letter). Eur J Anaesthesiol (2009); 26: 791. 10.1097/EJA.0b013e32832ac3a6 PubMedWeb of Science®Google Scholar Boffito M, Jackson A, Lamorde M, Back D, Watson V, Taylor J, Waters L, Asboe D, Gazzard B, Pozniak A. Pharmacokinetics and safety of etravirine administered once or twice daily after 2 weeks treatment with efavirenz in healthy volunteers. J Acquir Immune Defic Syndr Hum Retrovirol (2009); 52: 222. 10.1097/QAI.0b013e3181b061d0 Web of Science®Google Scholar Busse KH, Hadigan C, Chairez C, Alfaro RM, Formentini E, Kovacs JA, Penzak SR. Gemfibrozil concentrations are significantly decreased in the presence of lopinavir-ritonavir. J Acquir Immune Defic Syndr Hum Retrovirol (2009); 52: 235. 10.1097/QAI.0b013e3181b0610e Web of Science®Google Scholar Cervero M, Navas E, Agud JL, Garcia-Benaya E, Mon C. Atazanavir-related renal insufficiency without concurrent tenofovir (Letter) (Spanish). Enferm Infecc Microbiol Clin (2009); 27: 489. 10.1016/j.eimc.2008.12.007 PubMedWeb of Science®Google Scholar Cheah CY, De Keulenaer B, Leahy MF. Fluoroquinolone-induced immune thrombocytopenia: A report and review. Intern Med J (2009); 39: 619. 10.1111/j.1445-5994.2009.01996.x CASPubMedWeb of Science®Google Scholar Chen CP, Hsu YH, Hong SJ. Acute generalized exanthematous pustulosis caused by rifabutin (Letter). Arch Dermatol (2009); 145: 1069. 10.1001/archdermatol.2009.221 PubMedWeb of Science®Google Scholar Cohen N, Mihu CN, Seo SK, Chung D, Chou J, Heller G, Papanicolaou GA. Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2009); 15: 1337. 10.1016/j.bbmt.2009.05.021 CASPubMedWeb of Science®Google Scholar Coombes R. Cervarix: Definately not the new MMR (Comment). Br Med J (2009); 339: b4124. 10.1136/bmj.b4124 Web of Science®Google Scholar Cortese MM, Staat MA, Weinberg GA, Edwards K, Rice MA, Szilagyi PG, Hall CB, Payne DC, Parashar UD. Underestimates of intussusception rates among US infants based on inpatient discharge data: Implications for monitoring the safety of rotavirus vaccines. J Infect Dis (2009); 200: S264. 10.1086/605055 PubMedWeb of Science®Google Scholar Dubina MI, Fleischer AB. Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxide. Arch Dermatol (2009); 145: 1027. 10.1001/archdermatol.2009.186 CASPubMedWeb of Science®Google Scholar El Aidli S, Kastalli S, Zaiem A, Lakhoua G, Rejeibi I, Loueslati MH, Daghfous R, Belkahia C. Recurrent dysosmia induced by pyrazinamide. Fundam Clin Pharmacol (2009); 23: 539. 10.1111/j.1472-8206.2009.00736.x CASPubMedWeb of Science®Google Scholar Ferroir JP, Corpechot C, Freudenreich A, Khalil A. Metronidazole-related polyneuritis, convulsive seizures, and cerebellar syndrome. Contribution of MRI. Rev Neurol (Paris) (2009); 165: 828. PubMedWeb of Science®Google Scholar Fragasso G, Sanvito F, Baratto F, Martinenghi S, Doglioni C, Margonato A. Cardiotoxicity after low-dose chloroquine antimalarial therapy. Heart Vessels (2009); 24: 385. 10.1007/s00380-008-1144-8 PubMedWeb of Science®Google Scholar Ginsberg AM, Laurenzi MW, Rouse DJ, Whitney KD, Spigelman MK. Safety, tolerability and pharmacokinetics of PA-824 in healthy subjects. Antimicrob Agents Chemother (2009); 53: 3720. 10.1128/AAC.00106-09 CASPubMedWeb of Science®Google Scholar Gupta A, Tiwari SC, Mahajan S, Khaira A. Pedal oedema: A rare side-effect of faropenem (Letter). Nephrology (2009); 14: 702. 10.1111/j.1440-1797.2009.01139.x CASPubMedWeb of Science®Google Scholar Harro C, Sun X, Stek JE, Leavitt RY, Mehrotra DV, Wang FB, Bett AJ, Casimiro DR, Shiver JW, DiNubile MJ, Quirk E. Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults. Clin Vaccine Immunol (2009); 16: 1285. 10.1128/CVI.00144-09 CASPubMedWeb of Science®Google Scholar Hombhanje FW, Linge D, Saweri A, Kuanch C, Jones R, Toraso S, Geita J, Masta A, Kevau I, Hiawalyer G, Sapuri M. Artemisinin-naphthoquine combination (ARCO™) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: A preliminary report on safety and efficacy. Malaria J (2009); 8: 196. 10.1186/1475-2875-8-196 CASWeb of Science®Google Scholar Hsue PY, Hunt PW, Wu Y, Schnell A, Ho JE, Hatano H, Xie Y, Martin JN, Ganz P, Deeks SG. Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients. AIDS (2009); 23: 2021. 10.1097/QAD.0b013e32832e7140 CASPubMedWeb of Science®Google Scholar Hubert D, Leroy S, Nove-Josserand R, Murris-Esprin M, Mely L, Dominique S, Delaisi B, Kho P, Kovarik JM. Pharmacokinetics and safety of tobramycin administered by the PARI eFlow® rapid nebulizer in cystic fibrosis. J Cyst Fibros (2009); 8: 332. 10.1016/j.jcf.2009.07.001 CASPubMedWeb of Science®Google Scholar Kiuchi K, Miyashiro M, Kitagawa C, Wada S. Linezolid-associated optic neuropathy in a patient with ocular sarcoidosis. Jpn J Ophthalmol (2009); 53: 420. 10.1007/s10384-009-0678-3 PubMedWeb of Science®Google Scholar Knoell KA, Lynch JM. Photoinduced acute exanthematous pustulosis caused by ciprofloxacin and sunlight exposure (Letter). Int J Dermatol (2009); 48: 1141. 10.1111/j.1365-4632.2009.04115.x CASPubMedWeb of Science®Google Scholar Ku JY, Sharma A. Pegylated interferon and ribavirin therapy for hepatitis C causing cataract (Letter). Clin Exp Ophthalmol (2009); 37: 743. 10.1111/j.1442-9071.2009.02125.x CASWeb of Science®Google Scholar Lee YH, Lee HB, Kim JY, Lim YJ, Shin SA, Han TH. Antibiotic-induced severe neutropenia with multidrug-dependent antineutrophil antibodies developed in a child with Streptococcus pneumoniae infection. J Korean Med Sci (2009); 24: 975. 10.3346/jkms.2009.24.5.975 PubMedWeb of Science®Google Scholar Marino EA, Blanchard E, Samuel R, Gallagher J. Acute interstitial nephritis associated with linezolid (Letter). Ann Pharmacother (2009); 43: 1728. 10.1345/aph.1M270 PubMedWeb of Science®Google Scholar Maunz G, Conzett T, Zimmerli W. Cutaneous vasculitis associated with fluoroquinolones. Infection (2009); 37: 466. 10.1007/s15010-009-8437-4 CASPubMedWeb of Science®Google Scholar Menon V, Jain D, Saxena R, Sood R. Prospective evaluation of visual function for early detection of ethambutol toxicity. Br J Ophthalmol (2009); 93: 1251. 10.1136/bjo.2008.148502 CASPubMedWeb of Science®Google Scholar Montero M, Horcajada JP, Sorli L, Alvarez-Lerma F, Grau S, Riu M, Sala M, Knobel H. Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections. Infection (2009); 37: 461. 10.1007/s15010-009-8342-x CASPubMedWeb of Science®Google Scholar Nevin RL. Epileptogenic potential of mefloquine chemoprophylaxis: A pathogenic hypothesis. Malaria J (2009); 8: 188. 10.1186/1475-2875-8-188 CASPubMedWeb of Science®Google Scholar O'Dowd A. Teenager who died after having HPV vaccine had a malignant chest tumour (News). Brit Med J (2009); 339: b4032. 10.1136/bmj.b4032 PubMedWeb of Science®Google Scholar Phua KB, Lim FS, Lau YL, Nelson EAS, Huang LM, Quak SH, Lee BW, Teoh YL, Tang H, Boudville I, Oostvogels LC, Suryakiran PV, Smolenov IV, Han HH, Bock HL. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study. Vaccine (2009); 27: 5936. 10.1016/j.vaccine.2009.07.098 CASPubMedWeb of Science®Google Scholar Pichichero ME, Gentile A, Giglio N, Alonso MM, Mentaberri MVF, Zareba G, Clarkson T, Gotelli C, Gotelli M, Yan LH, Treanor J. Mercury levels in premature and low birth weight newborn infants after receipt of thimerosal-containing vaccines. J Pediatr (2009); 155: 495. 10.1016/j.jpeds.2009.04.011 CASPubMedWeb of Science®Google Scholar Pongas GN, Lewis RE, Samonis G, Kontoyiannis DP. Voriconazole-associated zygomycosis: A significant consequence of evolving antifungal prophylaxis and immunosuppression practices?. Clin Microbiol Infect (2009); 15: 93. 10.1111/j.1469-0691.2009.02988.x PubMedWeb of Science®Google Scholar Sakoulas G, Moise PA. Is vancomycin ototoxicity a significant risk? (Reply). Antimicrob Agents Chemother (2009); 53: 4572. 10.1128/AAC.00537-09 PubMedWeb of Science®Google Scholar Sharma SK, Singla R, Sreenivas V, Kumar S, Jha B, Rathored J, Singh S. Acute viral hepatitis as a confounding factor in patients with antituberculosis treatment induced hepatotoxicity (Letter). Indian J Med Res (2009); 130: 200. PubMedWeb of Science®Google Scholar Shields RK, Martello JL, Potoski BA. Is vancomycin ototoxicity a significant risk? (Letter). Antimicrob Agents Chemother (2009); 53: 4572. 10.1128/AAC.00537-09 PubMedWeb of Science®Google Scholar Stafford N. Only 12% of Germans say they will have H1N1 vaccine after row blows up over safety of adjuvants. Br Med J (2009); 339: b4335. 10.1136/bmj.b4335 Web of Science®Google Scholar Van der Velden WJFM, Van Iersel TMP, Blijlevens NMA, Donnelly JP. Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11). BMC Med (2009); 7: 44. 10.1186/1741-7015-7-44 CASPubMedWeb of Science®Google Scholar Van Luin M, Gras L, Richter C, Van der Ende ME, Prins JM, De Wolf F, Burger DM, Wit FW. Efavirenz dose reduction is safe in patients with high plasma concentrations and may prevent efavirenz discontinuation. J Acquir Immune Defic Syndr Hum Retrovirol (2009); 52: 240. 10.1097/QAI.0b013e3181b061e6 Web of Science®Google Scholar Vick-Fragoso R, Hernandez-Oliva G, Cruz-Alcazar J, Amabile-Cuevas CF, Arvis P, Reimnitz P, Bogner JR. Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections. Infection (2009); 37: 407. 10.1007/s15010-009-8468-x CASPubMedWeb of Science®Google Scholar Walker NF, Kliner M, Turner D, Bhagani S, Cropley I, Hopkins S, Lipman M. Hepatotoxicity and antituberculosis therapy: Time to revise UK guidance? (Letter). Thorax (2009); 64: 918. 10.1136/thx.2009.115469 PubMedWeb of Science®Google Scholar Xu NA, Zhou WB, Li SY, Zhou GF, Zhang N, Liang JH. Clinical and MRI characteristics of levamisole-induced leukoencephalopathy in 16 patients. J Neuroimaging (2009); 19: 326. 10.1111/j.1552-6569.2008.00344.x CASPubMedWeb of Science®Google Scholar Zafrir Y, Agmon-Levin N, Shoenfeld Y. Post-influenza vaccination vasculitides: A possible new entity (Editorial). J Clin Rheumatol (2009); 15: 269. 10.1097/RHU.0b013e3181b56177 PubMedWeb of Science®Google Scholar 4. Cardiovascular System Agents Google Scholar Ahmed M, Sra JU, Akhtar M, Mortada ME. A case of flecainide-induced hyponatremia. J Cardiovasc Electrophysiol (2009); 20: 1170. 10.1111/j.1540-8167.2009.01450.x CASPubMedWeb of Science®Google Scholar Balieva F, Steinkjer B. Contact dermatitis to captopril. Contact Dermatitis (2009); 61: 177. 10.1111/j.160

Referência(s)